DHSC · DHSC_0067_2021-Q3
Department page: Department of Health and Social Care
| Data as at | Rating | End date | Whole-life cost |
|---|---|---|---|
| March 2024 | Red (NISTA's independent assessment) | 31 October 2024 | £218m (price basis not stated) |
| March 2025 | Amber (NISTA's independent assessment) | 31 October 2024 | £208.98m (price basis not stated) |
| March 2026 | Green (NISTA's independent assessment) | 31 March 2026 | £187.99m (in 2024/25 prices) |
Each year’s cost is shown with its price basis. Costs are not compared between years: the March 2024 and March 2025 reports state no price basis, and from March 2026 costs are in 2024/25 prices.
This is the department’s own commentary. It may use different prices from the table above, so its figures may not match.
Rating: NISTA/SRO Delivery Confidence Assessment (DCA) rating was AMBER following the NISTA Gate 4 review on 07/07/2025. The programme implemented the recommendations from that review and successfully went live on 01/10/2025. Therefore the SRO confidence at 31/03/2026 is GREEN. The Gate 5 assurance review is due to take place the week commencing 11/05/2026.
Schedule: Compared to financial year 24/25-Q4, the project's end-date at 25/26-Q4 changed from 31/10/2024 to 28/02/2026. This was because the programme go-live date was delayed by 18 months, the business case for the revised go-live date of 01/10/2025 was only approved in September 2025 and therefore this is the first opportunity to update the completion date.
Cost: Compared to financial year 24/25-Q4, the project's departmentally agreed Whole Life Cost at 25/26-Q4 remained the same.
Rating: Compared to financial year 23/24-Q4, the Infrastructure Project Authority's Delivery Confidence Assessment rating at 24/25-Q4 increased from RED to AMBER. This is primarily due to the following factors: the programme has implemented the recommendations from the review of roles and responsibilities to ensure there is sufficient capacity and capability within the programme team as well as the suppliers to deliver it. Programme governance now reflects best practice with clear leadership on the strategic aims of the programme, appropriate monitoring and oversight of delivery, as well as strong risk and issue management. There is an updated programme plan with no overlap between critical phases which has been approved by the Programme Board and by key stakeholders.
Schedule: Compared to financial year 23/24-Q4, the project's end-date at 24/25-Q4 remained at 31/10/2024. This is primarily due to the following factors: the project end date 31 October 2024 aligns with the current approved full business case, as agreed with the Department of Health and Social Care. The revised go-live date is 1 October 2025, with a programme end date of 30 April 2026. These will be agreed formally as part of the revised full business case, which is currently underway.
Cost: Compared to financial year 23/24-Q4, the project's departmentally agreed Whole Life Cost at 24/25-Q4 (measured in £m) decreased from 218 to 208. This is primarily due to the following factors: that the £208 million figure is derived from the current approved full business case, whereas the £218 million are derived from the outline business case.
Source: NISTA Annual Report 2024-25 (data)
Rating: Compared to financial year 22/23-Q4, the Delivery Confidence Assessment rating at 23/24-Q4 increased from Amber(SRO rating) to Red(IPA rating). This is primarily due to the following factors. Following recommendations from a Red Gate 0 report in February 2024, an action plan is under development and the programme is undergoing a re-planning exercise to determine a new go-live date._x000D_ Progress against the action plan will be assessed in an Assurance of Action Plan (AAP) review scheduled for May 2024.
Schedule: Compared to financial year 22/23-Q4, the project's end-date at 23/24-Q4 remained schedule to finish on 2024-10-31. This is primarily due to the following factors. Go-live of the new service will be delayed beyond 1 April 2024,which will impact on project end date. A re-planning exercise is underway to determine new go-live and project end dates.
Cost: Compared to financial year 22/23-Q4, the project's departmental-agree Whole Life Cost at 23/24-Q4 decreased from 301m. to 218m. This is primarily due to the following factors. Baseline Whole Life Costs have been updated to reflect the 7 year contract period as approved by HMT. Optional extension costs are not included and remain subject to HMT approval.
Source: IPA Annual Report 2023-24 (data)
Names, figures, dates, ratings and commentary are as the department reported them. Where a rating, cost or date is withheld, the file’s wording is shown. Every major project →